Mono Pharmacare share news and announcements
NSE: MONOPHARMAPharmaceuticals & Biotechnology
Share price at the NSE close on 23 Oct 2026. Previous close ₹8.90.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹15 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 16 Jul 2026
- 42.4
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 16 Jul 2026
- 0.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 16 Jul 2026
- 1.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 16 Jul 2026
- 1.79
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,000100.0% delivered
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Mono Pharmacare half-yearly results
The board met on 16 Jul 2026 to consider financial results and other business matters
Notice filed 9 Jul 2026
Mono Pharmacare annual reports, presentations and earnings calls
The company's own documents, latest first.Mono Pharmacare financials, year by year
Annual reports3
Mono Pharmacare share news and announcements
110 announcements, routine notices left out, newest first. Page 1 of 3.
Oct 2026
Sep 2026
17 Sep · Corporate action
9 Sep · Updates
3 Sep · Board meeting
Aug 2026
26 Aug · Board meeting
Jul 2026
16 Jul · Management
16 Jul · Management
2 Jul · Board meeting
Not held on this date
Jun 2026
12 Jun · Corporate action
3 Jun · Board meeting
May 2026
26 May · Board meeting
Apr 2026
Mar 2026
30 Mar · Management
30 Mar · Board meeting
Feb 2026
Jan 2026
24 Jan · Management
Nov 2025
29 Nov · Board meeting
29 Nov · Management
21 Nov · Board meeting
Not held on this date
18 Nov · Board meeting
Not held on this date
14 Nov · Board meeting
Not held on this date
6 Nov · Board meeting
Not held on this date
Oct 2025
1 Oct · Meeting
Sep 2025
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 17 Jul 2026Results0.00%−0.4 pts vs Nifty 500market median −0.7% · five sessions −7.4% (−8.0 pts vs Nifty 500) · volume 0.8× usual · The announcement (opens in a new tab)
- 17 Jul 2026Board or managers changed0.00%−0.4 pts vs Nifty 500market median 0.0% · five sessions −7.4% (−8.0 pts vs Nifty 500) · volume 0.8× usual · The announcement (opens in a new tab)
- 6 May 2026Board or managers changedup 4.80%+3.4 pts vs Nifty 500market median 0.0% · five sessions −8.0% (−7.0 pts vs Nifty 500) · volume 0.2× usual · The announcement (opens in a new tab)
- 20 Mar 2026Board or managers changedup 4.27%+3.8 pts vs Nifty 500market median 0.0% · five sessions −4.7% (−3.7 pts vs Nifty 500) · volume 0.1× usual · The announcement (opens in a new tab)
- 27 Jan 2026Board or managers changeddown 4.61%−5.1 pts vs Nifty 500market median 0.0% · five sessions −12.9% (−13.5 pts vs Nifty 500) · volume 2.0× usual · The announcement (opens in a new tab)
- 1 Dec 2025Board or managers changeddown 4.99%−4.9 pts vs Nifty 500market median 0.0% · five sessions −11.1% (−9.4 pts vs Nifty 500) · volume 0.6× usual · The announcement (opens in a new tab)
- 2 Jun 2025Resultsdown 4.96%−5.1 pts vs Nifty 500market median −0.7% · five sessions −5.8% (−7.4 pts vs Nifty 500) · volume 1.3× usual · The announcement (opens in a new tab)
- 29 Jul 2024Board or managers changeddown 4.51%−6.6 pts vs Nifty 500market median 0.0% · five sessions −1.8% (−0.1 pts vs Nifty 500) · volume 6.3× usual · The announcement (opens in a new tab)
- 21 Dec 2023Board or managers changedup 5.68%+4.8 pts vs Nifty 500market median 0.0% · five sessions +3.2% (−0.3 pts vs Nifty 500) · volume 0.8× usual · The announcement (opens in a new tab)
Mono Pharmacare results filing dates and deadlines
Listed companies must file half-yearly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.